With two weeks to go, confusion surrounds hep C drug advice
19th February 2016
By David Rowley
A LACK of clarity surrounds prescribing guidelines for new-generation hepatitis C drugs that are set to be PBS authority-listed in two weeks.
Log In
Welcome to AusDoc.Plus, the new home of Australian Doctor, Medical Observer, 6minutes and How to Treat. You can use your existing login credentials for any of these sites to gain entry.
Not a member?
Join AusDoc.PLUS
Register
To ensure you get the right membership, please select your vocation: